RVinONE - Rhinoviruses

Tampere Tuberculosis Foundation, Finnish Allergy Research Foundation, Tampere University Doctoral School and Finnish Society for Study of Infectious Diseases funded – RVinONE – all-in-one rhinovirus vaccine project aims to develop a vaccine protecting against all rhinoviruses (RVs). Rhinoviruses are the most common cause of the flu throughout the year. In addition, rhinoviruses are a key factor in exacerbating allergy, lung and respiratory diseases causing among other things acute asthma.